Evolent Health, Inc.
EVH
$4.20
$0.000.00%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -22.83% | -31.34% | -24.39% | 16.27% | 21.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -22.83% | -31.34% | -24.39% | 16.27% | 21.60% |
| Cost of Revenue | -29.77% | -36.34% | -28.82% | 25.62% | 39.87% |
| Gross Profit | 23.65% | -6.04% | -1.57% | -25.50% | -35.15% |
| SG&A Expenses | 19.26% | 10.16% | 11.54% | 4.93% | -27.04% |
| Depreciation & Amortization | -20.49% | -22.53% | -18.46% | -1.03% | -8.34% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.43% | -30.77% | -23.96% | 22.37% | 25.30% |
| Operating Income | 105.34% | -70.00% | -70.76% | -102.15% | -334.19% |
| Income Before Tax | 15.99% | -1,625.92% | -277.79% | 50.23% | 23.05% |
| Income Tax Expenses | 246.37% | -246.64% | 160.18% | 92.35% | 88.85% |
| Earnings from Continuing Operations | 9.82% | -1,346.68% | -273.95% | 31.75% | 8.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.82% | -1,346.68% | -273.95% | 31.75% | 8.64% |
| EBIT | 105.34% | -70.00% | -70.76% | -102.15% | -334.19% |
| EBITDA | 68.45% | -37.51% | -32.96% | 31.65% | -64.31% |
| EPS Basic | 13.17% | -691.56% | -183.48% | 26.98% | 8.02% |
| Normalized Basic EPS | 25.70% | -355.83% | -2,449.28% | -127.11% | -152.46% |
| EPS Diluted | 13.17% | -691.56% | -183.48% | 26.98% | 8.02% |
| Normalized Diluted EPS | 25.70% | -355.83% | -2,449.28% | -127.11% | -152.46% |
| Average Basic Shares Outstanding | -0.69% | 1.04% | 1.03% | 1.27% | 2.30% |
| Average Diluted Shares Outstanding | -0.69% | 1.04% | 1.03% | 1.27% | 2.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.58% | -1.07% | 0.76% | -0.36% | -0.10% |